Requirement of PKR Dimerization Mediated by Specific Hydrophobic Residues for Its Activation by Double-Stranded RNA and Its Antigrowth Effects in Yeast

REFERENCES

• Barber, G. N., S. Thompson, T. G. Lee, T. Strom, R. Jagus, A. Darveau, and M. G. Katze 1994. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc. Natl. Acad. Sci. USA 91: 4278–4282.
   PubMedGoogle Scholar
• Barber, G. N., J. Tomita, M. S. Garfinkel, E. Meurs, A. Hovanessian, and M. G. Katze 1992. Detection of protein kinase homologues and viral RNA-binding domains utilizing polyclonal antiserum prepared against a baculovirus-expressed ds RNA-activated 68,000-Da protein kinase. Virology 191: 670–679.
   PubMedGoogle Scholar
• Bischoff, J. R., and C. E. Samuel 1985. Mechanism of interferon action: the interferon-induced phosphoprotein P1 possesses a double-stranded RNA-dependent ATP-binding site. J. Biol. Chem. 260: 8237–8239.
   PubMedGoogle Scholar
• Black, T. L., B. Safer, A. Hovanessian, and M. G. Katze 1989. The cellular 68,000- Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J. Virol. 63: 2244–2251.
   PubMed Web of Science ®Google Scholar
• Bycroft, M., S. Grunert, A. G. Murzin, M. Proctor, and D. St. Johnston 1995. NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal protein S5. EMBO J. 14: 3563–3571.
   PubMed Web of Science ®Google Scholar
• Carey, M., H. Kakidani, J. Leatherwood, F. Mostashari, and M. Ptashne 1989. An amino-terminal fragment of GAL4 binds DNA as a dimer. J. Mol. Biol. 209: 423–432.
   PubMed Web of Science ®Google Scholar
• Carpick, B. W., V. Graziano, D. Schneider, R. K. Maitra, X. Lee, and B. R. G. Williams 1997. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J. Biol. Chem. 272: 9510–9516.
   PubMedGoogle Scholar
• Chong, K. L., L. Feng, K. Schappert, E. Meurs, T. F. Donahue, J. D. Friesen, A. G. Hovanessian, and B. R. Williams 1992. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11: 1553–1562.
   PubMed Web of Science ®Google Scholar
• Colthurst, D. R., D. G. Campbell, and C. G. Proud 1987. Structure and regulation of eukaryotic initiation factor eIF-2. Sequence of the site in the alpha subunit phosphorylated by the haem-controlled repressor and by the double-stranded RNA-activated inhibitor. Eur. J. Biochem. 166: 357–363.
   PubMedGoogle Scholar
• Cosentino, G. P., S. Venkatesan, F. C. Serluca, S. R. Green, M. B. Mathews, and N. Sonenberg 1995. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA 92: 9445–9449.
   PubMedGoogle Scholar
• Craig, A. W., G. P. Cosentino, O. Donze, and N. Sonenberg 1996. The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. J. Biol. Chem. 271: 24526–24533.
   PubMedGoogle Scholar
• Davies, M. V., O. Elroy-Stein, R. Jagus, B. Moss, and R. J. Kaufman 1992. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66: 1943–1950.
   PubMedGoogle Scholar
• Der, S. D., Y. L. Yang, C. Weissmann, and B. R. G. Williams 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 3279–3283.
   PubMed Web of Science ®Google Scholar
• Dubois, M. F., and A. G. Hovanessian 1990. Modified subcellular localization of interferon-induced p68 kinase during encephalomyocarditis virus infection. Virology 179: 591–598.
   PubMedGoogle Scholar
• Feng, G. S., K. Chong, A. Kumar, and B. R. G. Williams 1992. Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc. Natl. Acad. Sci. USA 89: 5447–5451.
   PubMed Web of Science ®Google Scholar
• Galabru, J., and A. G. Hovanessian 1987. Autophosphorylation of the protein kinase dependent on double-stranded RNA. J. Biol. Chem. 262: 15538–15544.
   PubMedGoogle Scholar
• George, C. X., D. C. Thomis, S. J. McCormack, C. M. Svahn, and C. E. Samuel 1996. Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase. Virology 221: 180–188.
   PubMedGoogle Scholar
• Green, S. R., and M. B. Mathews 1992. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev. 6: 2478–2490.
   PubMedGoogle Scholar
• Hershey, J. W. B. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60: 717–755.
   PubMed Web of Science ®Google Scholar
• Hovanessian, A. G. 1989. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J. Interferon Res. 9: 641–647.
   PubMedGoogle Scholar
• Hovanessian, A. G., and J. Galabru 1987. The double-stranded RNA-dependent protein kinase is also activated by heparin. Eur. J. Biochem. 167: 467–473.
   PubMedGoogle Scholar
• Imani, F., and B. L. Jacobs 1988. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA 85: 7887–7891.
   PubMed Web of Science ®Google Scholar
• Judaware, R., and R. Petryshyn 1991. Partial characterization of a cellular factor that regulates the double-stranded RNA-dependent eIF2a kinase in 3T3-F442A fibroblasts. Mol. Cell. Biol. 11: 3259–3267.
   PubMedGoogle Scholar
• Katze, M. G. 1995. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3: 75–78.
   PubMedGoogle Scholar
• Katze, M. G. 1992. The war against the interferon-induced dsRNA-activated protein kinase: can viruses win? J. Interferon Res. 12: 241–248.
   PubMedGoogle Scholar
• Katze, M. G., M. Wambach, M. L. Wong, M. Garfinkel, E. Meurs, K. Chong, B. R. Williams, A. G. Hovanessian, and G. N. Barber 1991. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000- Mr protein kinase in a cell-free system. Mol. Cell. Biol. 11: 5497–5505.
   PubMed Web of Science ®Google Scholar
• Kharrat, A., M. J. Macias, T. J. Gibson, M. Nilges, and A. Pastore 1995. Structure of the dsRNA binding domain of E. coli RNase III. EMBO J. 14: 3572–3584.
   PubMed Web of Science ®Google Scholar
• Kitajewski, J., R. J. Schneider, B. Safer, S. M. Munemitsu, C. E. Samuel, B. Thimmappaya, and T. Shenk 1986. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 45: 195–200.
   PubMed Web of Science ®Google Scholar
• Koromilas, A. E., S. Roy, G. N. Barber, M. G. Katze, and N. Sonenberg 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257: 1685–1689.
   PubMed Web of Science ®Google Scholar
• Kumar, A., J. Haque, J. Lacoste, J. Hiscott, and B. R. G. Williams 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA 91: 6288–6292.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Y. L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, and B. R. G. Williams 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16: 406–416.
   PubMed Web of Science ®Google Scholar
• Lee, S. B., and M. Esteban 1994. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199: 491–496.
   PubMed Web of Science ®Google Scholar
• Lee, T. G., J. Tomita, A. G. Hovanessian, and M. G. Katze 1990. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA 87: 6208–6212.
   PubMed Web of Science ®Google Scholar
• Lengyel, P. 1993. Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. USA 90: 5893–5895.
   PubMed Web of Science ®Google Scholar
• Manche, L., S. R. Green, C. Schmedt, and M. B. Mathews 1992. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12: 5238–5248.
   PubMed Web of Science ®Google Scholar
• Maran, A., R. K. Maitra, A. Kumar, B. Dong, W. Xiao, G. Li, B. R. Williams, P. F. Torrence, and R. H. Silverman 1994. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265: 789–792.
   PubMed Web of Science ®Google Scholar
• Marcus, P. I., and M. J. Sekellick 1988. Interferon induction by viruses. XVI. 2-Aminopurine blocks selectively and reversibly an early stage in interferon induction. J. Virol. 69: 1637–1645.
   Google Scholar
• McCormack, S. J., L. G. Ortega, J. P. Doohan, and C. E. Samuel 1994. Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. Virology 198: 92–99.
   PubMedGoogle Scholar
• McCormack, S. J., D. C. Thomis, and C. E. Samuel 1992. Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. Virology 188: 47–56.
   PubMedGoogle Scholar
• McMillan, N. A., B. W. Carpick, B. Hollis, W. M. Toone, D. M. Zamanian, and B. R. G. Williams 1995. Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR. J. Biol. Chem. 270: 2601–2606.
   PubMedGoogle Scholar
• Meurs, E., K. Chong, J. Galabru, N. S. Thomas, I. M. Kerr, B. R. Williams, and A. G. Hovanessian 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62: 379–390.
   PubMed Web of Science ®Google Scholar
• Meurs, E. F., J. Galabru, G. N. Barber, M. G. Katze, and A. G. Hovanessian 1993. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 90: 232–236.
   PubMed Web of Science ®Google Scholar
• Meurs, E. F., Y. Watanabe, S. Kadereit, G. N. Barber, M. G. Katze, K. Chong, B. R. Williams, and A. G. Hovanessian 1992. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66: 5804–5814.
   Google Scholar
• Murre, C., S. P. McCaw, and D. Baltimore 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD and myc proteins. Cell 56: 777–783.
   PubMed Web of Science ®Google Scholar
• Olsen, H. S., A. W. Cochrane, P. J. Dillon, C. M. Nalin, and C. A. Rosen 1990. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation through a basic stretch of amino acids. Genes Dev. 4: 1357–1364.
   PubMed Web of Science ®Google Scholar
• O’Malley, R. P., T. M. Mariano, J. Siekierka, and M. B. Mathews 1986. A mechanism for the control of protein synthesis by adenovirus VA RNAI. Cell 44: 391–400.
   PubMedGoogle Scholar
• Ortega, L. G., M. D. McCotter, G. L. Henry, S. J. McCormack, D. C. Thomis, and C. E. Samuel 1996. Mechanism of interferon action. Biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells. Virology 215: 31–39.
   PubMedGoogle Scholar
• Patel, R. C., and G. C. Sen 1994. Characterization of the interactions between double-stranded RNA and the double-stranded RNA binding domain of the interferon induced protein kinase. Cell. Mol. Biol. Res. 40: 671–682.
   PubMedGoogle Scholar
• Patel, R. C., and G. C. Sen 1992. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267: 7671–7676.
   PubMed Web of Science ®Google Scholar
• Patel, R. C., P. Stanton, N. M. J. McMillan, B. R. G. Williams, and G. C. Sen 1995. The interferon-inducible double-stranded RNA-activated protein kinase, PKR, self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA 92: 8283–8287.
   PubMedGoogle Scholar
• Patel, R. C., P. Stanton, and G. C. Sen 1994. Role of the amino-terminal residues of the interferon-induced protein kinase in its activation by double-stranded RNA and heparin. J. Biol. Chem. 269: 18593–18598.
   PubMedGoogle Scholar
• Patel, R. C., P. Stanton, and G. C. Sen 1996. Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271: 25657–25663.
   PubMedGoogle Scholar
• Petryshyn, R., J.-J. Chen, and I. M. London 1984. Growth-related expression of a double-stranded RNA-dependent protein kinase in 3T3 cells. J. Biol. Chem. 259: 14736–14742.
   PubMedGoogle Scholar
• Romano, P. R., S. R. Green, G. N. Barber, M. B. Mathews, and A. G. Hinnebusch 1995. Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF2a kinase DAI in Saccharomyces cerevisiae. Mol. Cell. Biol. 15: 365–378.
   PubMedGoogle Scholar
• Sadowski, I., and M. Ptashne 1989. A vector for expressing GAL4 (1–147) fusions in mammalian cells. Nucleic Acids Res. 17: 7539.
   PubMed Web of Science ®Google Scholar
• Samuel, C. E. 1993. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268: 7603–7606.
   PubMed Web of Science ®Google Scholar
• Sikorski, R. S., and P. Hieter 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122: 19–27.
   PubMed Web of Science ®Google Scholar
• Sonenberg, N. 1990. Measures and countermeasures in the modulation of initiation factor activities by viruses. New Biol. 2: 402–409.
   PubMedGoogle Scholar
• St. Johnston, D., N. H. Brown, J. G. Gall, and M. Jantsch 1992. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA 89: 10979–10983.
   PubMed Web of Science ®Google Scholar
• Tan, S.-L., Gale, M. J.Jr., and M. G. Katze 1998. Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor. Mol. Cell. Biol. 18: 2431–2443.
   PubMedGoogle Scholar
• Tiwari, R. K., J. Kusari, R. Kumar, and G. C. Sen 1988. Gene induction by interferons and double-stranded RNA: selective inhibition by 2-aminopurine. Mol. Cell. Biol. 8: 4289–4294.
   PubMed Web of Science ®Google Scholar
• Whitaker-Dowling, P. A., and J. S. Youngner 1984. Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase activity. Virology 137: 171–181.
   PubMedGoogle Scholar
• Wong, A. H., N. W. Tam, Y. L. Yang, A. R. Cuddihy, S. Li, S. Kirchhoff, H. Hauser, T. Decker, and A. E. Koromilas 1997. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16: 1291–1304.
   PubMedGoogle Scholar
• Wu, S., and R. J. Kaufman 1996. Double-stranded (ds) RNA binding and not dimerization correlates with the activation of the dsRNA-dependent protein kinase (PKR). J. Biol. Chem. 271: 1756–1763.
   PubMedGoogle Scholar
• Zapp, M. L., T. J. Hope, T. G. Parslow, and M. R. Green 1991. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci. USA 88: 7734–7738.
   PubMed Web of Science ®Google Scholar
• Zinn, K., A. Keller, L.-A. Whittemore, and T. Maniatis 1988. 2-Aminopurine selectively inhibits the induction of β-interferon, c-fos, and c-myc gene expression. Science 240: 210–213.
   PubMed Web of Science ®Google Scholar